Net Sales (USD, millions)

Cost of Goods Sold (USD, millions)

Gross Profit (USD, millions)

Selling, General and Administrative Expenses (USD, millions)

Interest Income (USD, millions)

Interest Expense (USD, millions)

Foreign Exchange (Losses) Gains - Net (USD, millions)

Other Income (Expense) - Net (USD, millions)

Income (Loss) from Affiliates (USD, millions)

Income (Loss) Before Income Tax (USD, millions)

Income Tax (Expense) Benefit (USD, millions)

Income Tax Expense (USD, millions)

Net Income (Loss) (USD, millions)

Net (Income) Loss Attributable to Noncontrolling Interests and Redeemable Noncontrolling Interests (USD, millions)

Net Income (Loss) Attributable to Bunge Shareholders (USD, millions)

dfba9bca22ce2c90ff7d456b4371bbf85b7c791836a82cbd7909931c85b3d114

Net income (loss) [USD, millions]

Impairment charges [USD, millions]

Foreign exchange (gain) loss on net debt [USD, millions]

Depreciation, depletion and amortization [USD, millions]

Share-based compensation expense [USD, millions]

Deferred income tax expense (benefit) [USD, millions]

Results from affiliates [USD, millions]

Other, net (adjustments) [USD, millions]

Trade accounts receivable (changes) [USD, millions]

Inventories (changes) [USD, millions]

Secured advances to suppliers (changes) [USD, millions]

Trade accounts payable and accrued liabilities (changes) [USD, millions]

Advances on sales (changes) [USD, millions]

Net unrealized (gains) losses on derivative contracts [USD, millions]

Margin deposits (changes) [USD, millions]

Recoverable and income taxes, net (changes) [USD, millions]

Marketable securities (changes) [USD, millions]

Other, net (changes in operating assets/liabilities) [USD, millions]

Cash provided by (used for) operating activities [USD, millions]

Payments made for capital expenditures [USD, millions]

Proceeds from investments [USD, millions]

Payments for investments [USD, millions]

Settlements of net investment hedges [USD, millions]

Proceeds from disposals of businesses and property, plant and equipment [USD, millions]

Proceeds from investments in affiliates [USD, millions]

Payments for investments in affiliates [USD, millions]

Other, net (investing activities) [USD, millions]

Cash provided by (used for) investing activities [USD, millions]

Net change in short-term debt with maturities of three months or less [USD, millions]

Proceeds from short-term debt with maturities greater than three months [USD, millions]

Repayments of short-term debt with maturities greater than three months [USD, millions]

Proceeds from long-term debt [USD, millions]

Repayments of long-term debt [USD, millions]

Repurchases of registered shares [USD, millions]

Dividends paid to registered and common shareholders [USD, millions]

Capital contributions from (Return of capital to) noncontrolling interest [USD, millions]

Other, net (financing activities) [USD, millions]

Cash provided by (used for) financing activities [USD, millions]

Effect of exchange rate changes on cash and cash equivalents, and restricted cash [USD, millions]

Net increase (decrease) in cash and cash equivalents, and restricted cash [USD, millions]

Cash and cash equivalents, and restricted cash - beginning of period [USD, millions]

Cash and cash equivalents, and restricted cash - end of period [USD, millions]

7076d824ddeed0480ba848f64f5835e7066897d96f5122eb75d6394c08cb8717

BG's cash and cash equivalents fell dramatically in Q2 2024 due to several factors. **Operating activities** turned negative with cash used of **$480 million**, partially driven by lower net income and increased working capital needs (notably higher inventory volumes and timing differences in payments) compared to the previous period.  **[0001996862-24-000194_bg-20240630.htm:57]** **[0001996862-24-000192_epr06302024.htm:5]**  Additionally, **investing activities** consumed **$548 million** of cash, while **financing activities** shifted from providing cash in the prior period to using **$388 million** in Q2 2024.  **[0001996862-24-000194_bg-20240630.htm:57]**  A minor **$6 million negative impact** from exchange rate changes also contributed to the overall decline, resulting in a cumulative drop of nearly **$1,422 million** in the first half of 2024.  **[0001996862-24-000194_bg-20240630.htm:51]** **[0001996862-24-000194_bg-20240630.htm:57]** 

Why did Cash and cash equivalents drop so dramatically in Q2 2024?

The decline in Q2 2024 was driven by several factors. **Total assets** dropped by **$944 million**, primarily due to a substantial decrease in **cash and cash equivalents**—down by **$1,441 million** as a result of share repurchases, dividend payments, and other operational cash outflows—as well as a **$315 million** fall in **trade accounts receivable** linked to lower net sales. Additionally, there were reductions in **other current assets** (**$94 million**), **goodwill** (**$23 million**), and **other intangible assets** (**$43 million**), though these were partially offset by an **inventory** increase of **$952 million**.  **[0001996862-24-000194_bg-20240630.htm:3]** **[0001996862-24-000194_bg-20240630.htm:51]** **[0001996862-24-000194_bg-20240630.htm:52]** **[0001996862-24-000194_bg-20240630.htm:56]** 

What drove the decline in Total assets in Q2 2024?

The **Current portion of long-term debt** spiked in Q3 2024 because the **1.63% Senior Notes due in 2025** were reclassified as part of the current portion of long-term debt, increasing the amount from **$5 million** at year-end 2023 to **$663 million** as of September 30, 2024.  **[0001996862-24-000259_bg-20240930.htm:33]** **[0001996862-24-000259_bg-20240930.htm:58]** 

Why did the current portion of long-term debt spike in Q3 2024?

The surge in long-term debt in Q3 2024 was primarily driven by the issuance of **three tranches of unsecured senior notes** totaling **$2.0 billion**, which was part of a financing strategy to support the **Viterra acquisition** and related expenses. This increase raised the debt from **$4,085 million** at the end of FY 2023 to **$5,440 million** by September 30, 2024, an increase of **$1,355 million**, partially offset by the **prepayment of a $750 million 3-year term loan due in 2025**.  **[0001996862-24-000259_bg-20240930.htm:60]** **[0001996862-24-000259_bg-20240930.htm:33]** 

What factors contributed to the surge in Long-term debt in Q3 2024?

819746440ba398f70a9cbab5e030a41d628bbb76f162b8ab0a3d5754cf42c923

Cash and cash equivalents (USD, millions)

Trade accounts receivable (USD, millions)

Inventories (USD, millions)

Other current assets (USD, millions)

Total current assets (USD, millions)

Property, plant and equipment, net (USD, millions)

Operating lease assets (USD, millions)

Investments in affiliates (USD, millions)

Other non-current assets (USD, millions)

Total assets (USD, millions)

Short-term debt (USD, millions)

Current portion of long-term debt (USD, millions)

Trade accounts payable (USD, millions)

Current operating lease obligations (USD, millions)

Other current liabilities (USD, millions)

Total current liabilities (USD, millions)

Long-term debt (USD, millions)

Non-current operating lease obligations (USD, millions)

Other non-current liabilities (USD, millions)

Redeemable noncontrolling interest (USD, millions)

Total equity (USD, millions)

Total liabilities, redeemable noncontrolling interest and equity (USD, millions)

91550c8992278b95433d01236d04a6e609cdad55a086eaab0fa3b35c0379f0a5

Total Revenue [USD, Millions]

Cost of Goods Sold (COGS) [USD, Millions]

SG&A [USD, Millions]

R&D [USD, Millions]

D&A [USD, Millions]

Interest Expense [USD, Millions]

Operating Income (EBIT) [USD, Millions]

Net Income [USD, Millions]

EPS - Basic [USD, Per Share]

EPS - Diluted [USD, Per Share]

648129f18c663eb4874681049d68b0dc60264ba10f371cdd7a64e2226a8b6ab7

Adjustments for Non-Cash Items

Stock-Based Compensation

Changes in Working Capital

Capital Expenditures (CapEx)

Proceeds from / Repayments of Debt

Share Repurchases

Dividend Payments

Net Change in Cash

01f2787251997f2f2573f276923ad23f23ddd639bc3106477b031ca995bd5a13

Current Assets [USD, Millions]

Cash and Cash Equivalents [USD, Millions]

Accounts Receivable [USD, Millions]

Inventory [USD, Millions]

Non-Current Assets [USD, Millions]

PP&E [USD, Millions]

Goodwill [USD, Millions]

Intangible Assets [USD, Millions]

Current Liabilities [USD, Millions]

Accounts Payable [USD, Millions]

Short-term Debt [USD, Millions]

Accrued Expenses [USD, Millions]

Non-Current Liabilities [USD, Millions]

Long-term Debt [USD, Millions]

Lease Liabilities [USD, Millions]

Deferred Tax Liabilities [USD, Millions]

Shareholders' Equity [USD, Millions]

Retained Earnings [USD, Millions]

Common Stock [USD, Millions]

Additional Paid-in Capital [USD, Millions]

c5ebb8d0ab24dd6510b88644c1aaef0fefd65b654c7b827a00ec862527b5b766

Volumes for Agribusiness Segment (thousand metric tons)

Volumes for Refined and Specialty Oils Segment (thousand metric tons)

Volumes for Milling Segment (thousand metric tons)

a666ad642bd0de4847fdb0e88269a5121805beb8f41ec3987233a275a6dd4617

Europe

United States

Asia-Pacific

Brazil

Argentina

Canada

Rest of World

Total Revenue

85420cd08199cbe1104cd3e9d460e69191e4fee4cd1d8138dce8ef9eac89a10f

Agribusiness

- Processing Products

- Merchandising Products

Refined and Specialty Oils

Milling

Sugar and Bioenergy

Corporate & Other

b49f7f27ce77c362f8f1fb84f9e195629d920a0b9df01039841066d457fac96f

Bunge Global (BG)

Financials